These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hydroxyethyl starch and granulocyte transfusions: considerations of utility and toxicity profile for patients and donors. Ambruso DR Transfusion; 2015 Apr; 55(4):911-8. PubMed ID: 25315227 [TBL] [Abstract][Full Text] [Related]
23. Does albumin interfere with coagulation-related outcomes when comparing colloids in cardiac surgery? Durukan AB; Tavlasoglu M; Gurbuz HA J Thorac Cardiovasc Surg; 2013 Jan; 145(1):309-10. PubMed ID: 23244263 [No Abstract] [Full Text] [Related]
24. Excessive use of hetastarch: An iatrogenic cause of bleeding and hypocalcemia? Haynes GR; Bailey MK Anesth Analg; 2000 Jun; 90(6):1455-6. PubMed ID: 10825341 [No Abstract] [Full Text] [Related]
25. An international review of HES. Riou B; Cittanova ML Intensive Care Med; 1999 Nov; 25(11):1340-1. PubMed ID: 10654230 [No Abstract] [Full Text] [Related]
26. Data too important to share: do those who control the data control the message? Doshi P BMJ; 2016 Mar; 352():i1027. PubMed ID: 26936297 [No Abstract] [Full Text] [Related]
27. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501 [TBL] [Abstract][Full Text] [Related]
33. Hydroxyethyl starch solutions and patient harm. Roberts I; Shakur H; Bellomo R; Bion J; Finfer S; Hunt B; Myburgh J; Perner A; Reinhart K Lancet; 2018 Feb; 391(10122):736. PubMed ID: 29449012 [No Abstract] [Full Text] [Related]
34. Is the use of hydroxyethyl starch as priming solution during cardiac surgery advisable? A randomized, single-center trial. Svendsen ØS; Farstad M; Mongstad A; Haaverstad R; Husby P; Kvalheim VL Perfusion; 2018 Sep; 33(6):483-489. PubMed ID: 29199540 [TBL] [Abstract][Full Text] [Related]
35. [Hydroxyethyl starch : position statement by the Presidents of the DGAI (German Society of Anaesthesiology and Intensive Care Medicine), the BDA (Professional Association of German Anaesthetists) and the DAAF (German Academy for Further Education in Anaesthesiology)]. Werner C; Geldner G; Koch T Anaesthesist; 2013 Aug; 62(8):595-6. PubMed ID: 23925464 [No Abstract] [Full Text] [Related]
36. European hydroxyethyl starch: a safe and inexpensive alternative to albumin. Treib J; Haass A; Schimrigk K Anesth Analg; 1997 Sep; 85(3):709. PubMed ID: 9296444 [No Abstract] [Full Text] [Related]
38. Risks of hydroxyethyl starch 130/0.4 in cardiac surgery. Haynes GR J Pharm Pract; 2014 Feb; 27(1):17-8. PubMed ID: 24436438 [No Abstract] [Full Text] [Related]
39. The nephrotoxicity of 6% Hydroxyethyl Starch 130/0.4 in surgery. Kancir AS Acta Anaesthesiol Scand; 2016 Apr; 60(4):548-9. PubMed ID: 26941118 [No Abstract] [Full Text] [Related]
40. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Choi YS; Shim JK; Hong SW; Kim JC; Kwak YL Minerva Anestesiol; 2010 Aug; 76(8):584-91. PubMed ID: 20661198 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]